Obesity Drug Market Peak Shrinks as Pricing, Competition and Pills Reshape the Outlook
Wall Street projections that the global obesity-treatment market would climb to $150 billion or more within a decade are being revised downward. Rapid price declines in U.S. retail and direct-to-consumer channels, the launch of oral formulations and the prospect of generics have prompted analysts to lower peak-market estimates and push expected tim…